Ginsenoside Rg3 attenuates pulmonary fibrosis by inhibiting endothelial to mesenchymal transition

References

• Assayag M, Goldstein S, Samuni A, Berkman N. 2021. 3-Carbamoyl-proxyl nitroxide radicals attenuate bleomycin-induced pulmonary fibrosis in mice. Free Radic Biol Med. 171:135–142. doi:10.1016/j.freeradbiomed.2021.05.010.
   PubMed Web of Science ®Google Scholar
• Cavarra E, Carraro F, Fineschi S, Naldini A, Bartalesi B, Pucci A, Lungarella G. 2004. Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs. Am J Physiol Lung Cell Mol Physiol. 287(6):L1186–1192. doi:10.1152/ajplung.00170.2004.
   PubMed Web of Science ®Google Scholar
• Chen Y, Yuan T, Zhang H, Yan Y, Wang D, Fang L, Lu Y, Du G. 2017. Activation of Nrf2 attenuates pulmonary vascular remodeling via inhibiting endothelial-to-mesenchymal transition: an insight from a plant polyphenol. Int J Biol Sci. 13(8):1067–1081. doi:10.7150/ijbs.20316.
   PubMed Web of Science ®Google Scholar
• Cho JG, Lee A, Chang W, Lee MS, Kim J. 2018. Endothelial to mesenchymal transition represents a Key link in the interaction between inflammation and endothelial dysfunction. Front Immunol. 9:294. doi:10.3389/fimmu.2018.00294.
   PubMed Web of Science ®Google Scholar
• Choi SH, Hong ZY, Nam JK, Lee HJ, Jang J, Yoo RJ, Lee YJ, Lee CY, Kim KH, Park S, et al. 2015. A hypoxia-induced vascular endothelial-to-mesenchymal transition in development of radiation-induced pulmonary fibrosis. Clin Cancer Res. 21(16):3716–3726. doi:10.1158/1078-0432.CCR-14-3193.
   PubMed Web of Science ®Google Scholar
• Cipriani P, Di Benedetto P, Ruscitti P, Capece D, Zazzeroni F, Liakouli V, Pantano I, Berardicurti O, Carubbi F, Pecetti G, et al. 2015. The endothelial-mesenchymal transition in systemic sclerosis Is induced by endothelin-1 and transforming growth factor-β and may be blocked by macitentan, a dual endothelin-1 receptor antagonist. J Rheumatol. 42(10):1808–1816. doi:10.3899/jrheum.150088.
   PubMed Web of Science ®Google Scholar
• Fu Z, Xu YS, Cai CQ. 2021. Ginsenoside Rg3 inhibits pulmonary fibrosis by preventing HIF-1α nuclear localisation. BMC Pulm Med. 21(1):70. doi:10.1186/s12890-021-01426-5.
   PubMed Web of Science ®Google Scholar
• Gaikwad AV, Lu W, Dey S, Bhattarai P, Chia C, Larby J, Haug G, Myers S, Jaffar J, Westall G, et al. 2022. Vascular remodelling in idiopathic pulmonary fibrosis patients and its detrimental effect on lung physiology: potential role of endothelial-to-mesenchymal transition. ERJ Open Res. 8(1.
   Google Scholar
• Geng J, Fu W, Yu X, Lu Z, Liu Y, Sun M, Yu P, Li X, Fu L, Xu H, et al. 2020. Ginsenoside Rg3 alleviates ox-LDL induced endothelial dysfunction and prevents atherosclerosis in ApoE−/− mice by regulating PPARγ/FAK signaling pathway. Front Pharmacol. 11:500. doi:10.3389/fphar.2020.00500.
   PubMed Web of Science ®Google Scholar
• Ghosh AK, Nagpal V, Covington JW, Michaels MA, Vaughan DE. 2012. Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): differential expression of microRNAs during EndMT. Cell Signal. 24(5):1031–1036. doi:10.1016/j.cellsig.2011.12.024.
   PubMed Web of Science ®Google Scholar
• Girao-Silva T, Fonseca-Alaniz MH, Ribeiro-Silva JC, Lee J, Patil NP, Dallan LA, Baker AB, Harmsen MC, Krieger JE, Miyakawa AA. 2021. High stretch induces endothelial dysfunction accompanied by oxidative stress and actin remodeling in human saphenous vein endothelial cells. Sci Rep. 11(1):13493. doi:10.1038/s41598-021-93081-3.
   PubMed Web of Science ®Google Scholar
• Guan X, Yuan Y, Wang G, Zheng R, Zhang J, Dong B, Ran N, Hsu AC, Wang C, Wang F. 2020. Ginsenoside Rg3 ameliorates acute exacerbation of COPD by suppressing neutrophil migration. Int Immunopharmacol. 83:106449. doi:10.1016/j.intimp.2020.106449.
   PubMed Web of Science ®Google Scholar
• Hasan M, Paul NC, Paul SK, Saikat ASM, Akter H, Mandal M, Lee SS. 2022. Natural product-based potential therapeutic interventions of pulmonary fibrosis. Molecules. 27(5):1481. doi:10.3390/molecules27051481.
   PubMed Web of Science ®Google Scholar
• Hashimoto N, Phan SH, Imaizumi K, Matsuo M, Nakashima H, Kawabe T, Shimokata K, Hasegawa Y. 2010. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 43(2):161–172. doi:10.1165/rcmb.2009-0031OC.
   PubMed Web of Science ®Google Scholar
• Hien TT, Kim ND, Pokharel YR, Oh SJ, Lee MY, Kang KW. 2010. Ginsenoside Rg3 increases nitric oxide production via increases in phosphorylation and expression of endothelial nitric oxide synthase: essential roles of estrogen receptor-dependent PI3-kinase and AMP-activated protein kinase. Toxicol Appl Pharmacol. 246(3):171–183. doi:10.1016/j.taap.2010.05.008.
   PubMed Web of Science ®Google Scholar
• Huang Q, Gan Y, Yu Z, Wu H, Zhong Z. 2021. Endothelial to mesenchymal transition: an insight in atherosclerosis. Front Cardiovasc Med. 8:734550. doi:10.3389/fcvm.2021.734550.
   PubMed Web of Science ®Google Scholar
• Hubner RH, Gitter W, El Mokhtari NE, Mathiak M, Both M, Bolte H, Freitag-Wolf S, Bewig B. 2008. Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques. 44(4):507–511. doi:10.2144/000112729.
   PubMed Web of Science ®Google Scholar
• Jia W, Wang Z, Gao C, Wu J, Wu Q. 2021. Trajectory modeling of endothelial-to-mesenchymal transition reveals galectin-3 as a mediator in pulmonary fibrosis. Cell Death Dis. 12(4):327. doi:10.1038/s41419-021-03603-0.
   PubMed Web of Science ®Google Scholar
• Kai Y, Tomoda K, Yoneyama H, Kitabatake M, Nakamura A, Ito T, Yoshikawa M, Kimura H. 2017. Silencing of carbohydrate sulfotransferase 15 hinders murine pulmonary fibrosis development. Mol Ther Nucleic Acids. 6:163–172. doi:10.1016/j.omtn.2016.12.008.
   PubMedGoogle Scholar
• Kanasaki K, Shi S, Kanasaki M, He J, Nagai T, Nakamura Y, Ishigaki Y, Kitada M, Srivastava SP, Koya D. 2014. Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen. Diabetes. 63(6):2120–2131. doi:10.2337/db13-1029.
   PubMed Web of Science ®Google Scholar
• Katikireddy KR, White TL, Miyajima T, Vasanth S, Raoof D, Chen Y, Price MO, Price FW, Jurkunas UV. 2018. NQO1 downregulation potentiates menadione-induced endothelial-mesenchymal transition during rosette formation in Fuchs endothelial corneal dystrophy. Free Radic Biol Med. 116:19–30. doi:10.1016/j.freeradbiomed.2017.12.036.
   PubMed Web of Science ®Google Scholar
• Kim J. 2018. MicroRNAs as critical regulators of the endothelial to mesenchymal transition in vascular biology. BMB Rep. 51(2):65–72. doi:10.5483/BMBRep.2018.51.2.011.
   PubMed Web of Science ®Google Scholar
• Kim SM, Huh JW, Kim EY, Shin MK, Park JE, Kim SW, Lee W, Choi B, Chang EJ. 2019. Endothelial dysfunction induces atherosclerosis: increased aggrecan expression promotes apoptosis in vascular smooth muscle cells. BMB Rep. 52(2):145–150. doi:10.5483/BMBRep.2019.52.2.282.
   PubMed Web of Science ®Google Scholar
• Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J. 2001. Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest. 107(12):1529–1536. doi:10.1172/JCI12568.
   PubMed Web of Science ®Google Scholar
• Lee A, Yun E, Chang W, Kim J. 2020. Ginsenoside Rg3 protects against iE-DAP–induced endothelial-to-mesenchymal transition by regulating the miR-139-5p–NF-κB axis. J Ginseng Res. 44(2):300–307. doi:10.1016/j.jgr.2019.01.003.
   PubMed Web of Science ®Google Scholar
• Liu H, Lv C, Lu J. 2020a. Panax ginseng C. A. Meyer as a potential therapeutic agent for organ fibrosis disease. Chin Med. 15(1):124. doi:10.1186/s13020-020-00400-3.
   PubMed Web of Science ®Google Scholar
• Liu M, Zhang T, Zang C, Cui X, Li J, Wang G. 2020b. Preparation, optimization, and in vivo evaluation of an inhaled solution of total saponins of Panax notoginseng and its protective effect against idiopathic pulmonary fibrosis. Drug Deliv. 27(1):1718–1728. doi:10.1080/10717544.2020.1856222.
   PubMed Web of Science ®Google Scholar
• Liu S, Xu DS, Li M, Zhang Y, Li Q, Li TT, Ren LQ. 2021. Icariin attenuates endothelial-mesenchymal transition via H19/miR-148b-3p/ELF5 in ox-LDL-stimulated HUVECs. Mol Ther Nucleic Acids. 23:464–475. doi:10.1016/j.omtn.2020.11.021.
   PubMedGoogle Scholar
• Liu YM, Nepali K, Liou JP. 2017. Idiopathic pulmonary fibrosis: current status, recent progress, and emerging targets. J Med Chem. 60(2):527–553. doi:10.1021/acs.jmedchem.6b00935.
   PubMed Web of Science ®Google Scholar
• Lu P, Su W, Miao ZH, Niu HR, Liu J, Hua QL. 2008. Effect and mechanism of ginsenoside Rg3 on postoperative life span of patients with non-small cell lung cancer. Chin J Integr Med. 14(1):33–36. doi:10.1007/s11655-007-9002-6.
   PubMed Web of Science ®Google Scholar
• Ma H, Liu S, Li S, Xia Y. 2022. Targeting growth factor and cytokine pathways to treat idiopathic pulmonary fibrosis. Front Pharmacol. 13:918771. doi:10.3389/fphar.2022.918771.
   PubMed Web of Science ®Google Scholar
• Ma J, Sanchez-Duffhues G, Goumans MJ, Ten Dijke P. 2020. TGF-β-Induced endothelial to mesenchymal transition in disease and tissue engineering. Front Cell Dev Biol. 8:260. doi:10.3389/fcell.2020.00260.
   PubMed Web of Science ®Google Scholar
• Maleszewska M, Moonen JR, Huijkman N, van de Sluis B, Krenning G, Harmsen MC. 2013. IL-1β and TGFβ2 synergistically induce endothelial to mesenchymal transition in an NFκB-dependent manner. Immunobiology. 218(4):443–454. doi:10.1016/j.imbio.2012.05.026.
   PubMed Web of Science ®Google Scholar
• Martin M, Zhang J, Miao Y, He M, Kang J, Huang HY, Chou CH, Huang TS, Hong HC, Su SH, et al. 2021. Role of endothelial cells in pulmonary fibrosis via SREBP2 activation. JCI Insight. 6(22). doi:10.1172/jci.insight.125635.
   Web of Science ®Google Scholar
• Meng L, Ji R, Dong X, Xu X, Xin Y, Jiang X. 2019. Antitumor activity of ginsenoside Rg3 in melanoma through downregulation of the ERK and Akt pathways. Int J Oncol. 54(6):2069–2079.
   PubMed Web of Science ®Google Scholar
• Moeller A, Ask K, Warburton D, Gauldie J, Kolb M. 2008. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol. 40(3):362–382. doi:10.1016/j.biocel.2007.08.011.
   PubMed Web of Science ®Google Scholar
• Monteiro JP, Rodor J, Caudrillier A, Scanlon JP, Spiroski AM, Dudnakova T, Pfluger-Muller B, Shmakova A, von Kriegsheim A, Deng L, et al. 2021. Mir503hg loss promotes endothelial-to-mesenchymal transition in vascular disease. Circ Res. 128(8):1173–1190. doi:10.1161/CIRCRESAHA.120.318124.
   PubMed Web of Science ®Google Scholar
• Nagar H, Choi S, Jung SB, Jeon BH, Kim CS. 2016. Rg3-enriched Korean Red Ginseng enhances blood pressure stability in spontaneously hypertensive rats. Integr Med Res. 5(3):223–229. doi:10.1016/j.imr.2016.05.006.
   PubMedGoogle Scholar
• Nakhjavani M, Smith E, Yeo K, Palethorpe HM, Tomita Y, Price TJ, Townsend AR, Hardingham JE. 2021. Anti-Angiogenic properties of Ginsenoside Rg3 epimers: in Vitro assessment of single and combination treatments. Cancers (Basel). 13(9.
   PubMed Web of Science ®Google Scholar
• Nie L, Lyros O, Medda R, Jovanovic N, Schmidt JL, Otterson MF, Johnson CP, Behmaram B, Shaker R, Rafiee P. 2014. Endothelial-mesenchymal transition in normal human esophageal endothelial cells cocultured with esophageal adenocarcinoma cells: role of IL-1β and TGF-β2. Am J Physiol Cell Physiol. 307(9):C859–877. doi:10.1152/ajpcell.00081.2014.
   PubMed Web of Science ®Google Scholar
• Pardali E, Sanchez-Duffhues G, Gomez-Puerto MC, Ten Dijke P. 2017. TGF-beta-Induced endothelial-mesenchymal transition in fibrotic diseases. Int J Mol Sci. 18(10.
   PubMed Web of Science ®Google Scholar
• Park JB, Kwon SK, Nagar H, Jung SB, Jeon BH, Kim CS, Oh JH, Song HJ, Kim CS. 2014. Rg3-enriched Korean Red Ginseng improves vascular function in spontaneously hypertensive rats. J Ginseng Res. 38(4):244–250. doi:10.1016/j.jgr.2014.05.011.
   PubMed Web of Science ®Google Scholar
• Pei B, Zhang N, Pang T, Sun G. 2022. Linagliptin ameliorates pulmonary fibrosis in systemic sclerosis mouse model via inhibition of endothelial-to-mesenchymal transition. Mol Cell Biochem. 477(4):995–1007. doi:10.1007/s11010-021-04349-1.
   PubMed Web of Science ®Google Scholar
• Peng Z, Wu WW, Yi P. 2020. The efficacy of Ginsenoside Rg3 combined with first-line chemotherapy in the treatment of advanced Non-small cell lung cancer in China: a systematic review and meta-analysis of randomized clinical trials. Front Pharmacol. 11:630825. doi:10.3389/fphar.2020.630825.
   PubMed Web of Science ®Google Scholar
• Polosukhin VV, Degryse AL, Newcomb DC, Jones BR, Ware LB, Lee JW, Loyd JE, Blackwell TS, Lawson WE. 2012. Intratracheal bleomycin causes airway remodeling and airflow obstruction in mice. Exp Lung Res. 38:135–146. doi:10.3109/01902148.2012.658595.
   PubMed Web of Science ®Google Scholar
• Reynolds AM, Holmes MD, Danilov SM, Reynolds PN. 2012. Targeted gene delivery of BMPR2 attenuates pulmonary hypertension. Eur Respir J. 39(2):329–343. doi:10.1183/09031936.00187310.
   PubMed Web of Science ®Google Scholar
• Roh JS, Jeong H, Lee B, Song BW, Han SJ, Sohn DH, Lee SG. 2021. Mirodenafil ameliorates skin fibrosis in bleomycin-induced mouse model of systemic sclerosis. Anim Cells Syst (Seoul). 25(6):387–395. doi:10.1080/19768354.2021.1995486.
   PubMed Web of Science ®Google Scholar
• Shah PV, Balani P, Lopez AR, Nobleza CMN, Siddiqui M, Khan S. 2021. A review of pirfenidone as an anti-fibrotic in idiopathic pulmonary fibrosis and Its probable role in other diseases. Cureus. 13(1):e12482.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Tada Y, Gladson S, Nishimura R, Shimomura I, Karasawa S, Tatsumi K, West J. 2017. Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition. Respir Res. 18(1):177. doi:10.1186/s12931-017-0660-4.
   PubMedGoogle Scholar
• Todd NW, Luzina IG, Atamas SP. 2012. Molecular and cellular mechanisms of pulmonary fibrosis. Fibrogenesis Tissue Repair. 5(1):11. doi:10.1186/1755-1536-5-11.
   PubMedGoogle Scholar
• Tsai KD, Yang SM, Lee JC, Wong HY, Shih CM, Lin TH, Tseng MJ, Chen W. 2011. Panax notoginseng attenuates bleomycin-induced pulmonary fibrosis in mice. Evid Based Complement Alternat Med. 2011:404761.
   PubMed Web of Science ®Google Scholar
• Wang J, Li X, Zhong M, Wang Y, Zou L, Wang M, Gong X, Wang X, Zhou C, Ma X, et al. 2020. miR-301a suppression within fibroblasts limits the progression of fibrosis through the TSC1/mTOR pathway. Mol Ther Nucleic Acids. 21:217–228.
   PubMedGoogle Scholar
• Wang X, Chen L, Wang T, Jiang X, Zhang H, Li P, Lv B, Gao X. 2015. Ginsenoside Rg3 antagonizes adriamycin-induced cardiotoxicity by improving endothelial dysfunction from oxidative stress via upregulating the Nrf2-ARE pathway through the activation of akt. Phytomedicine. 22(10):875–884. doi:10.1016/j.phymed.2015.06.010.
   PubMed Web of Science ®Google Scholar
• Warrior K, Chung PA, Reid M, Bemiss BC. 2021. Use of nintedanib and pirfenidone in non-idiopathic pulmonary fibrosis lung disease. Am J Respir Crit Care Med. 204(1):92–94. doi:10.1164/rccm.202012-4356RR.
   PubMed Web of Science ®Google Scholar
• Wollin L, Wex E, Pautsch A, Schnapp G, Hostettler KE, Stowasser S, Kolb M. 2015. Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis. Eur Respir J. 45(5):1434–1445. doi:10.1183/09031936.00174914.
   PubMed Web of Science ®Google Scholar
• Yang J, Li S, Wang L, Du F, Zhou X, Song Q, Zhao J, Fang R. 2018. Ginsenoside Rg3 attenuates lipopolysaccharide-induced acute lung injury via MerTK-dependent activation of the PI3K/AKT/mTOR pathway. Front Pharmacol. 9:850. doi:10.3389/fphar.2018.00850.
   PubMed Web of Science ®Google Scholar
• Yun E, Kook Y, Yoo KH, Kim KI, Lee MS, Kim J, Lee A. 2020. Endothelial to mesenchymal transition in pulmonary vascular diseases. Biomedicines. 8(12.
   Web of Science ®Google Scholar
• Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R. 2008. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol. 19(12):2282–2287. doi:10.1681/ASN.2008050513.
   PubMed Web of Science ®Google Scholar
• Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, et al. 2007. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med. 13(8):952–961. doi:10.1038/nm1613.
   PubMed Web of Science ®Google Scholar
• Zhang LP, Jiang YC, Yu XF, Xu HL, Li M, Zhao XZ, Sui DY. 2016. Ginsenoside Rg3 improves cardiac function after myocardial ischemia/reperfusion via attenuating apoptosis and inflammation. Evid Based Complement Alternat Med. 2016:6967853.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li C, Huang Y, Zhao S, Xu Y, Chen Y, Jiang F, Tao L, Shen X. 2020. A risk score system based on DNA methylation levels and a nomogram survival model for lung squamous cell carcinoma. Int J Mol Med. 46(1):252–264. doi:10.3892/ijmm.2020.4590.
   PubMed Web of Science ®Google Scholar
• Zhu GX, Zuo JL, Xu L, Li SQ. 2021. Ginsenosides in vascular remodeling: cellular and molecular mechanisms of their therapeutic action. Pharmacol Res. 169:105647. doi:10.1016/j.phrs.2021.105647
   PubMed Web of Science ®Google Scholar